XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.
| Revenue (TTM) | $52.15M |
| Gross Profit (TTM) | $50.44M |
| EBITDA | $14.36M |
| Operating Margin | 15.90% |
| Return on Equity | 34.10% |
| Return on Assets | 2.88% |
| Revenue/Share (TTM) | $4.32 |
| Book Value | $7.07 |
| Price-to-Book | 5.92 |
| Price-to-Sales (TTM) | 9.62 |
| EV/Revenue | 46.73 |
| EV/EBITDA | 11.40 |
| Quarterly Earnings Growth (YoY) | -47.80% |
| Quarterly Revenue Growth (YoY) | 57.90% |
| Shares Outstanding | $12.13M |
| Float | $8.98M |
| % Insiders | 4.18% |
| % Institutions | 72.45% |
Volatility is currently expanding